Synopsys Is Silently Building a Picks-and-Shovels Moat in The Global AI Chip Buildout
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) has pulled back again, and the latest dip puts its long-term case back in focus. Nearly every advanced AI chip gets designed, verified and simulated on software from a small group of vendors, and Synopsys leads that group. No matter which chipmaker wins the AI race, the winner’s designs run through tools like these, and Synopsys takes a toll on that work.
AI Complexity Is the Tailwind Driving Synopsys
AI chips keep getting harder to build. Multi-die architectures, advanced packaging and heat management all add engineering hours, and those hours run on Synopsys tools. On the fiscal Q3 call, management said AI design starts have continued accelerating while non-AI design starts stabilized over the last two quarters. NVIDIA (NASDAQ:NVDA) held 4,821,717 Synopsys shares worth $2,150,823,302 as of June 30, 2026. That stake ties the most important AI chip designer directly to its toolmaker.
Three Reasons Synopsys Keeps Compounding
First, the company keeps growing and keeps raising its guidance. Fiscal Q3 revenue reached $2.48 billion, up 42.4% year over year, and non-GAAP EPS of $3.91 beat the $3.6733 consensus. The Ansys acquisition expands that revenue comparison, so I track the core business separately. Management expects double-digit organic EDA revenue growth for full-year 2026. Current full-year non-GAAP EPS guidance is now $15.04 to $15.10, replacing the previous initial range of $14.32 to $14.40.
Second, the cash keeps getting stronger. Current free cash flow guidance is roughly $2.6 billion after Q3, replacing the previous February outlook of roughly $1.9 billion. The third quarter alone produced $746 million.
Third, the moat keeps getting deeper. Synopsys won more than 95% of PCIe 7 opportunities and has more than 100 cumulative die-to-die design wins. Its Factory 2 custom IP model adds royalties on top of licensing, which ties Synopsys to hyperscaler custom silicon for years. At a forward P/E of about 25x, the stock trades well below its trailing multiple. The trailing multiple of 83x looks ugly because of acquisition amortization.
Why Synopsys Stands Out Against Cadence
Cadence Design Systems (NASDAQ:CDNS) is the name most readers reach for first, and it runs a fine business. The numbers still favor Synopsys on scale. Cadence carries a market value of $90.995 billion and guides fiscal 2026 revenue to $6.387 billion to $6.417 billion with operating cash flow of approximately $2.0 billion. Synopsys trades at $88.14 billion while guiding to $9.690 billion to $9.740 billion in revenue and about $2.6 billion in free cash flow. Synopsys offers a larger revenue base and more cash for a smaller market value.
Debt and Export Controls Are the Risks I Watch
The Ansys deal left Synopsys with approximately $10 billion of total debt. Amortization of acquired intangible assets runs about $403.6 million per quarter and weighs on GAAP earnings. Export rules worry me more. Guidance assumes no further changes to export control restrictions or Entity List restrictions, and the company depends on a relatively small number of large customers. Shares fell 9.81% over the past month.
Management keeps chipping away at these risks. Synopsys repaid $3.46 billion of long-term debt in the first half of fiscal 2026, paid off term loans earlier than planned and finished Q3 with $3.606 billion in cash. Synopsys pays no dividend, so shareholder returns depend on that cash compounding inside the business.
Catalysts That Could Power Synopsys Through the Next Decade
Multiphysics Fusion, the first joint Synopsys-Ansys product, should start contributing to EDA growth in 2027. Management remains committed to $400 million in synergies by year four, and the board refilled a $2.0 billion buyback authorization. Over the past ten years, the stock returned 671.34%. Every advanced AI chip of the next decade needs design software before it ever reaches a fab, and Synopsys sells that software (we featured seven more suppliers quietly driving the AI expansion, from power to cooling to design tools, in a free report you can grab here).
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
